Why Is Everyone Talking About Johnson & Johnson Stock?
Johnson & Johnson (NYSE: JNJ) is seen by investors as one of the most reliable companies around. The company has raised its dividend for 58 consecutive years. That reputation had been tarnished by litigation in the last decade, but management's announcement of progress toward a vaccine for COVID-19 offered hope the blue chip's once pristine image could be regained. Despite the fact that its clinical trials trail other companies from a timeline perspective, one detail will have people once again praising the company.
Image source: Getty Images.
When people have talked about Johnson & Johnson in the last few years, it's often been about a product that harmed its customers. Settlements and judgments ranging from hundreds of millions of dollars to billions for faulty medical devices, misleading marketing, questionable testing, and contaminants have dominated recent headlines.
Source Fool.com
